Genetically engineered bacterium with altered carbon monoxide dehydrogenase (CODH) activity

US9365873B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9365873-B2
Application numberUS-201514753191-A
CountryUS
Kind codeB2
Filing dateJun 29, 2015
Priority dateAug 11, 2014
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides genetically engineered microorganisms with altered carbon monoxide dehydrogenase (CODH) activity and methods related thereto. In particular, the invention provides a genetically engineered carboxydotrophic acetogenic bacterium having decreased or eliminated activity of CODH1 and/or CODH2. In certain embodiments, the bacterium may also have increased activity of CODH/ACS. The invention further provides a method for producing a product by culturing the bacterium in the presence of a gaseous substrate comprising one or more of carbon monoxide, carbon dioxide, and hydrogen.

First claim

Opening claim text (preview).

The invention claimed is: 1. A genetically engineered carboxydotrophic acetogenic bacterium having decreased or eliminated activity of CODH1 and/or CODH2 compared to a parental bacterium. 2. The bacterium of claim 1 , wherein the bacterium comprises at least one disruptive mutation in a CODH1 gene and/or CODH2 gene. 3. The bacterium of claim 2 , wherein the disruptive mutation decreases or eliminates expression of the CODH1 gene and/or the CODH2 gene compared to a parental bacterium. 4. The bacterium of claim 2 , wherein the disruptive mutation is a knockout mutation. 5. The bacterium of claim 1 , wherein the bacterium additionally has increased activity of CODH/ACS compared to the parental bacterium. 6. The bacterium of claim 5 , wherein the bacterium overexpresses a CODH/ACS gene compared to the parental bacterium. 7. The bacterium of claim 1 , wherein the bacterium produces one or more of ethanol and 2,3-butanediol. 8. The bacterium of claim 1 , wherein the bacterium produces a higher amount of ethanol, produces a lower amount of acetate, has a shorter lag phase, and/or has a higher growth rate compared to the parental bacterium. 9. The bacterium of claim 1 , wherein the bacterium consumes a gaseous substrate comprising one or more of CO, CO 2 , and H 2 . 10. The bacterium of claim 1 , wherein the parental bacterium is Clostridium autoethanogenum, Clostridium ljungdahlii , or Clostridium ragsdalei. 11. A method for producing a product, comprising culturing the bacterium of claim 1 in the presence of a gaseous substrate comprising one or more of CO, CO 2 , and H 2 , whereby the bacterium produces a product. 12. The method of claim 11 , wherein the bacterium comprises at least one disruptive mutation in a CODH1 gene and/or CODH2 gene. 13. The method of claim 12 , wherein the disruptive mutation decreased or eliminates expression of the CODH1 gene and/or the CODH2 gene compared to a parental bacterium. 14. The method of claim 12 , wherein the disruptive mutation is a knockout mutation. 15. The method of claim 11 , wherein the bacterium additionally has increased activity of CODH/ACS compared to the parental bacterium. 16. The method of claim 15 , wherein the bacterium overexpresses a CODH/ACS gene compared to the parental bacterium. 17. The method of claim 11 , wherein the product comprises one or more of ethanol and 2,3-butanediol. 18. The method of claim 11 , wherein the bacterium produces a higher amount of ethanol, produces a lower amount of acetate, has a shorter lag phase, and/or has a higher growth rate compared to the parental bacterium. 19. The method of claim 11 , wherein the parental bacterium is Clostridium autoethanogenum, Clostridium ljungdahlii , or Clostridium ragsdalei.

Assignees

Inventors

Classifications

  • Butanols · CPC title

  • C12N15/74Primary

    Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title

  • C12P7/065Primary

    with microorganisms other than yeasts · CPC title

  • C12P7/18Primary

    polyhydric · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9365873B2 cover?
The invention provides genetically engineered microorganisms with altered carbon monoxide dehydrogenase (CODH) activity and methods related thereto. In particular, the invention provides a genetically engineered carboxydotrophic acetogenic bacterium having decreased or eliminated activity of CODH1 and/or CODH2. In certain embodiments, the bacterium may also have increased activity of CODH/ACS. …
Who is the assignee on this patent?
Koepke Michael, Liew Fungmin, Lanzatech New Zealand Ltd
What technology area does this patent fall under?
Primary CPC classification C12N15/74. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).